DE69911726D1 - Derivate von Arylcarbonsäuren und Tetrazolen mit einer Carbamoyloxy-Gruppe - Google Patents

Derivate von Arylcarbonsäuren und Tetrazolen mit einer Carbamoyloxy-Gruppe

Info

Publication number
DE69911726D1
DE69911726D1 DE69911726T DE69911726T DE69911726D1 DE 69911726 D1 DE69911726 D1 DE 69911726D1 DE 69911726 T DE69911726 T DE 69911726T DE 69911726 T DE69911726 T DE 69911726T DE 69911726 D1 DE69911726 D1 DE 69911726D1
Authority
DE
Germany
Prior art keywords
tetrazoles
derivatives
carbamoyloxy group
arylcarboxylic acids
arylcarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69911726T
Other languages
English (en)
Other versions
DE69911726T2 (de
Inventor
Francisco Javier Lopez-Tapia
Alexander Victor Muehldorf
Counde O'yang
Daniel Lee Severance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69911726D1 publication Critical patent/DE69911726D1/de
Publication of DE69911726T2 publication Critical patent/DE69911726T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
DE69911726T 1998-12-23 1999-12-15 Derivate von Arylcarbonsäuren und Tetrazolen mit einer Carbamoyloxy-Gruppe Expired - Fee Related DE69911726T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11344698P 1998-12-23 1998-12-23
US113446P 1998-12-23
US15181499P 1999-08-30 1999-08-30
US151814P 2009-02-11

Publications (2)

Publication Number Publication Date
DE69911726D1 true DE69911726D1 (de) 2003-11-06
DE69911726T2 DE69911726T2 (de) 2004-07-29

Family

ID=26811078

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69911726T Expired - Fee Related DE69911726T2 (de) 1998-12-23 1999-12-15 Derivate von Arylcarbonsäuren und Tetrazolen mit einer Carbamoyloxy-Gruppe

Country Status (29)

Country Link
US (1) US6335459B1 (de)
EP (1) EP1013639B1 (de)
JP (1) JP3415085B2 (de)
KR (1) KR100378335B1 (de)
CN (1) CN1167670C (de)
AR (1) AR029320A1 (de)
AT (1) ATE251125T1 (de)
AU (1) AU735640B2 (de)
BR (1) BR9905974A (de)
CA (1) CA2292921C (de)
DE (1) DE69911726T2 (de)
DK (1) DK1013639T3 (de)
ES (1) ES2207108T3 (de)
HR (1) HRP990394A2 (de)
HU (1) HUP9904659A3 (de)
ID (1) ID25983A (de)
IL (1) IL133578A (de)
MA (1) MA26713A1 (de)
NO (1) NO316171B1 (de)
NZ (1) NZ501891A (de)
PE (1) PE20001368A1 (de)
PL (1) PL337419A1 (de)
PT (1) PT1013639E (de)
RU (1) RU2179969C2 (de)
SG (1) SG90086A1 (de)
TR (1) TR199903310A2 (de)
TW (1) TWI221834B (de)
UY (1) UY25876A1 (de)
YU (1) YU69699A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
JP2004526721A (ja) * 2001-03-02 2004-09-02 エフ．ホフマン−ラ　ロシュ　アーゲー Ｉｐアンタゴニストとしてのアルコキシカルボニルアミノヘテロアリールカルボン酸誘導体
JP4702054B2 (ja) 2003-05-09 2011-06-15 東レ株式会社 増強剤
UA93548C2 (uk) 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
US9669381B2 (en) 2007-06-27 2017-06-06 Hrd Corporation System and process for hydrocracking
KR20240024285A (ko) 2008-03-18 2024-02-23 아레나 파마슈티칼스, 인크. 프로스타시클린 （ｐｇｉ２） 수용체와 관련된 장애의 치료에 유용한 상기 수용체의 조절제
WO2010010909A1 (ja) 2008-07-23 2010-01-28 東レ株式会社 慢性腎不全処置剤
AU2011263416B2 (en) 2010-06-11 2014-04-10 Rhodes Technologies Process for N-dealkylation of tertiary amines
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
ES2965069T3 (es) 2017-03-01 2024-04-11 Arena Pharm Inc Composiciones que comprenden agonistas del receptor de PGI2 y procesos para la preparación de las mismas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1079414A (en) 1965-06-30 1967-08-16 Smith & Nephew Derivatives of acetic acid and a process for their preparation
GB1185539A (en) 1967-11-03 1970-03-25 Smith & Nephew Substituted Tetrazoles
DE2432560A1 (de) 1974-07-06 1976-01-22 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeurederivate und verfahren zur herstellung derselben
JPS5832859A (ja) 1981-08-20 1983-02-25 Dainippon Pharmaceut Co Ltd Ｎ，ｎ−ジメチルカルバミン酸ベンジルエステル誘導体
JPH0725725B2 (ja) 1987-07-23 1995-03-22 保土谷化学工業株式会社 ベンズアミド誘導体
US5084466A (en) 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2090283A1 (en) 1992-02-28 1993-08-29 Nobuyuki Hamanaka Phenoxyacetic acid derivatives
WO1995021863A1 (fr) 1994-02-10 1995-08-17 Ono Pharmaceutical Co., Ltd. Recepteur de la prostaglandine i¿2?
CN1057522C (zh) 1994-03-10 2000-10-18 藤泽药品工业株式会社 作为前列腺素i2激动剂的萘衍生物
US5753700A (en) 1994-12-28 1998-05-19 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
JP3909864B2 (ja) 1995-07-26 2007-04-25 小野薬品工業株式会社 ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
AUPP029197A0 (en) 1997-11-10 1997-12-04 Fujisawa Pharmaceutical Co., Ltd. Benzocycloheptene derivatives
AUPP109097A0 (en) 1997-12-22 1998-01-22 Fujisawa Pharmaceutical Co., Ltd. Napthalene derivatives

Also Published As

Publication number Publication date
HUP9904659A3 (en) 2000-12-28
KR100378335B1 (ko) 2003-03-29
AR029320A1 (es) 2003-06-25
TWI221834B (en) 2004-10-11
NO996366L (no) 2000-06-26
ID25983A (id) 2000-11-16
ES2207108T3 (es) 2004-05-16
MA26713A1 (fr) 2004-12-20
ATE251125T1 (de) 2003-10-15
CA2292921A1 (en) 2000-06-23
NO996366D0 (no) 1999-12-21
EP1013639B1 (de) 2003-10-01
PT1013639E (pt) 2004-02-27
AU6534099A (en) 2000-07-06
EP1013639A1 (de) 2000-06-28
YU69699A (sh) 2001-12-26
HU9904659D0 (en) 2000-02-28
PL337419A1 (en) 2000-07-03
RU2179969C2 (ru) 2002-02-27
UY25876A1 (es) 2001-07-31
HRP990394A2 (en) 2000-08-31
AU735640B2 (en) 2001-07-12
JP2000191523A (ja) 2000-07-11
SG90086A1 (en) 2002-07-23
BR9905974A (pt) 2000-09-12
HUP9904659A2 (hu) 2000-11-28
DE69911726T2 (de) 2004-07-29
PE20001368A1 (es) 2000-12-14
JP3415085B2 (ja) 2003-06-09
CN1167670C (zh) 2004-09-22
US6335459B1 (en) 2002-01-01
CN1266054A (zh) 2000-09-13
TR199903310A3 (tr) 2000-10-23
NO316171B1 (no) 2003-12-22
NZ501891A (en) 2001-10-26
CA2292921C (en) 2004-08-17
IL133578A (en) 2004-07-25
TR199903310A2 (xx) 2000-10-23
IL133578A0 (en) 2001-04-30
DK1013639T3 (da) 2004-02-09
KR20000048322A (ko) 2000-07-25

Similar Documents

Publication Publication Date Title
ATE263147T1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
CY2007020I1 (el) Ορισμενα 5-αλκυλο-2-αρυλαμινοφαινυλοξικα οξεα και παραγωγα
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
DE69727218D1 (de) Einschluss komplexe von aryl-heterokyhlishe salzen
DE69601572T2 (de) Schnellhärtende wässrige beschichtungszusammensetzung und farbe
DE122004000018I2 (de) 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromycin a derivate
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
EE9800339A (et) Aminoisokinoliinid ja aminotienopüridiini derivaadid ning nende kasutamine põletikuvastaste ainetena
DE60035581D1 (de) Salz von amlodipin und atorvastatin
ATE251125T1 (de) Derivate von arylcarbonsäuren und tetrazolen mit einer carbamoyloxy-gruppe
DE69801676D1 (de) Wässrige emulsionen von fischer-tropschparaffinen
DE69903143D1 (de) Chromanon und thiochromanon derivate
DE69524043D1 (de) Carbodiimide Derivate
FI964267A (fi) Porfosyaniini ja CNC-laajennetut porfyriinit
DE29718052U1 (de) Verbundschloß und Spundwand
DE69710305T2 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl
DE19581497T1 (de) Neue Derivate des Tetramethylcyclopropans
DE69802908D1 (de) Salicylsäure - sphingoidbase derivate und ihre verwendung
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
DE69839508D1 (de) Chinolinmorphinan-derivate und ihre medizinische anwendung
DE69803634T2 (de) Herstellung von Phenol und dessen Derivaten
MA26481A1 (fr) Derives d'arylsecocholadiene
DE69815244D1 (de) Galactosylierte hydroxyalkylpolysaccharide und ihre derivate
DE69715979T2 (de) Chinolinderivate und ihre Anwendung
NO993544D0 (no) Stabling av beholdere

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee